<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0372544</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">1822</journal-id>
      <journal-id journal-id-type="nlm-ta">Br J Haematol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Br. J. Haematol.</journal-id>
      <journal-title-group>
        <journal-title>British journal of haematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0007-1048</issn>
      <issn pub-type="epub">1365-2141</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25832012</article-id>
      <article-id pub-id-type="pmc">4490107</article-id>
      <article-id pub-id-type="doi">10.1111/bjh.13423</article-id>
      <article-id pub-id-type="manuscript">NIHMS685122</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Cross-sectional Study of Bleeding Phenotype in Haemophilia A Carriers</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Paroskie</surname>
            <given-names>Allison</given-names>
          </name>
          <degrees>MD, MSCI</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gailani</surname>
            <given-names>Dave</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>DeBaun</surname>
            <given-names>Michael R.</given-names>
          </name>
          <degrees>MD, MPH</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sidonio</surname>
            <given-names>Robert F.</given-names>
            <suffix>Jr</suffix>
          </name>
          <degrees>MD, MSC</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Vanderbilt University, Nashville, TN</aff>
      <aff id="A2"><label>2</label>Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, TN</aff>
      <aff id="A3"><label>3</label>Emory University, Children’s Healthcare of Atlanta; Atlanta, Georgia</aff>
      <author-notes>
        <corresp id="FN1">Address correspondence to: Robert F Sidonio Jr, MD MSC, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University, 1760 Haygood Drive; Health Sciences Research Building Suite 340; Atlanta, GA 30322, <email>robert.sidonio@choa.org</email>, (phone) 404-785-1637; (fax) 404-727-3681</corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>14</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>1</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>03</day>
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <volume>170</volume>
      <issue>2</issue>
      <fpage>223</fpage>
      <lpage>228</lpage>
      <!--elocation-id from pubmed: 10.1111/bjh.13423-->
      <abstract>
        <title>Summary</title>
        <p id="P2">Haemophilia A carriers have historically been thought to demonstrate normal haemostasis. However, recent data demonstrates that despite normal factor VIII, haemophilia A carriers demonstrate an increased bleeding tendency. We tested the hypothesis that obligate haemophilia carriers demonstrate an increase in bleeding symptoms. A cross sectional study was performed comparing haemophilia A carriers to normal women. Questionnaire assessment included a general bleeding questionnaire, condensed MCMDM-1VWD bleeding assessment tool and Pictorial Bleeding Assessment Chart (PBAC). Laboratory assessment included complete blood count, prothrombin time, activated partial thromboplastin time, fibrinogen activity, FVIII activity (FVIII:C), von Willebrand factor antigen level, ristocetin cofactor, platelet function analyser-100<sup>™</sup> and ABO blood type. 44 haemophilia A carriers and 43 controls were included. Demographic features were similar. Laboratory results demonstrated a statistically significant difference only in FVIII:C (82.5 versus 134%, p value &lt; 0.001). Carriers reported a higher number of bleeding events, and both condensed MCMDM-1 VWD bleeding scores (5 versus 1, p value &lt; 0.001) and PBAC scores (423 versus 182.5, p value = 0.018) were significantly higher in carriers. Haemophilia A carriers exhibit increased bleeding symptoms when compared to normal women. Further studies are necessary to fully understand the bleeding phenotype in this population and optimize clinical management.</p>
      </abstract>
      <kwd-group>
        <kwd>coagulation</kwd>
        <kwd>haemostasis</kwd>
        <kwd>Haemophilia</kwd>
        <kwd>factor VIII</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>

